Paroxysmal sympathetic storm (PSS), or diencephalic seizure, usually appears in patients with severe traumatic brain injury and is characterized by various sympathetic symptoms. The physiological effects of this syndrome are not well studied. The authors monitored intracranial pressure (ICP) in a patient with PSS and reviewed its impact on the physiology and management of the syndrome. A 12-year-old male patient was involved in a traffic accident. Upon arrival at the emergency room, his Glasgow Coma Scale score was 5 and he showed decerebration. A brain CT showed an intracerebral hematoma in the right basal ganglia, at which point craniotomy and removal of the hematoma were performed. Continuous intracranial monitoring was performed using the fiber-optic intraparenchymal method. Beginning the day after the trauma, the patient began exhibiting sympathetic symptoms including intermittent episodes of fever, tachycardia, increased blood pressure, tachypnea, diaphoresis and decerebrate rigidity. These episodes were accompanied by ICP elevation of greater than 20 mm Hg. ICP was decreased during hyperventilation, and the episodic symptoms subsided as ICP normalized. PaCO2 was periodically altered in association with hyperventilation. Electroencephalogram did not show epileptiform discharges, and the sympathetic spells were aborted by continuous intravenous midazolam infusion. The authors report on a pattern of ICP monitoring in association with PSS. Traumatic PSS should be recognized in the appropriate setting to prevent secondary brain damage.

1.
Rabinstein AA: Paroxysmal sympathetic hyperactivity in the neurological intensive care unit. Neurol Res 2007;29:680–682.
2.
Blackman JA, Patrick PD, Buck ML, Rust RS Jr: Paroxysmal autonomic instability with dystonia after brain injury. Arch Neurol 2004;61:321–328.
3.
Rovner RN: Diencephalic seizures: relation to periodic disease. Trans Am Neurol Assoc 1965;90:287–289.
4.
LeWitt PA, Newman RP, Greenberg HS, Rocher LL, Calne DB, Ehrenkranz JR: Episodic hyperhidrosis, hypothermia, and agenesis of corpus callosum. Neurology 1983;33:1122–1129.
5.
Carr-Locke D, Millac P: Diencephalic epilepsy in a patient with agenesis of the corpus callosum confirmed by computerised axial tomography. J Neurol Neurosurg Psychiatry 1977;40:808–814.
6.
Boeve BF, Wijdicks EF, Benarroch EE, Schmidt KD: Paroxysmal sympathetic storms (‘diencephalic seizures’) after severe diffuse axonal head injury. Mayo Clin Proc 1998;73:148–152.
7.
Bullard DE: Diencephalic seizures: responsiveness to bromocriptine and morphine. Ann Neurol 1987;21:609–611.
8.
Talman WT, Florek G, Bullard DE: A hyperthermic syndrome in two subjects with acute hydrocephalus. Arch Neurol 1988;45:1037–1040.
9.
Darnell RB, Arbit E: Reversible diencephalic dysfunction: episodic hyperhidrosis due to a trapped third ventricle. Neurology 1993;43:579–582.
10.
Goh KY, Conway EJ, DaRosso RC, Muszynski CA, Epstein FJ: Sympathetic storms in a child with a midbrain glioma: a variant of diencephalic seizures. Pediatr Neurol 1999;21:742–744.
11.
Diesing TS, Wijdicks EF: Arc de cercle and dysautonomia from anoxic injury. Mov Disord 2006;21:868–869.
12.
Penfield W: Diencephalic autonomic epilepsy. Arch Neurol Psychiatry 1929;22:358–374.
13.
Benarroch EE: The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc 1993;68:988–1001.
14.
Rabinstein AA, Benarroch EE: Treatment of paroxysmal sympathetic hyperactivity. Curr Treat Options Neurol 2008;10:151–157.
15.
Baguley IJ: Nomenclature of ‘paroxysmal sympathetic storms’. Mayo Clin Proc 1999;74:105.
16.
Huang P, Lin WC, Huang PK, Khor GT: Susceptibility weighted imaging in a patient with paroxysmal sympathetic storms. J Neurol 2009;256:276–278.
17.
Bernath O: Treatment of paroxysmal sympathetic storm with labetalol. J Neurol Neurosurg Psychiatry 2001;70:818–819.
18.
Rossitch E Jr, Bullard DE: The autonomic dysfunction syndrome: aetiology and treatment. Br J Neurosurg 1988;2:471–478.
19.
Carmel PW: Vegetative dysfunctions of the hypothalamus. Acta Neurochir (Wien) 1985;75:113–121.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.